Li G - Search Results

1

Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma.

Wang J, Li G, Ma H, Bao Y, Wang X, Zhou H, Sheng Z, Sugimura H, Jin J, Zhou X. Wang J, et al. Among authors: li g. Hum Pathol. 2007 Nov;38(11):1649-56. doi: 10.1016/j.humpath.2007.01.030. Epub 2007 Jul 31. Hum Pathol. 2007. PMID: 17669470

2

Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.

Wang JD, Dong YC, Sheng Z, Ma HH, Li GL, Wang XL, Lu GM, Sugimura H, Jin J, Zhou XJ. Wang JD, et al. Oncology. 2007;73(3-4):238-45. doi: 10.1159/000127421. Epub 2008 Apr 17. Oncology. 2007. PMID: 18424888

3

Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.

Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, Zhu RM, Li GL, Xia XY, Wei XW, Ji HZ, Lu H, Gao Y, Gao WM, Chen LB. Wang YC, et al. World J Gastroenterol. 2008 May 21;14(19):3074-80. doi: 10.3748/wjg.14.3074. World J Gastroenterol. 2008. PMID: 18494062 Free PMC article.

4

[Arteriovenous neoadjuvant FLEOX chemotherapy with nutritional support improves the resectable rate for advanced gastric cancer].

Li GL, Bao Y, Jiang J, Fan CG, Wang ZM, Li N, Li JS. Li GL, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2008 Sep;11(5):428-31. Zhonghua Wei Chang Wai Ke Za Zhi. 2008. PMID: 18803042 Chinese.

5

Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis.

Dong Y, Wang J, Sheng Z, Li G, Ma H, Wang X, Zhang R, Lu G, Hu Q, Sugimura H, Zhou X. Dong Y, et al. Among authors: li g. Mod Pathol. 2009 Jan;22(1):151-60. doi: 10.1038/modpathol.2008.188. Epub 2008 Nov 14. Mod Pathol. 2009. PMID: 19011600 Free article.

6

[Neoadjuvant chemotherapy of FLEEOX regimen for unresectable gastric cancer resulting from advanced abdominal lymph nodes metastases].

Li GL, Fan CG, Bao Y, Jiang J, Li N, Li JS. Li GL, et al. Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1171-4. Zhonghua Wai Ke Za Zhi. 2009. PMID: 20021910 Chinese.

7

Retrospective analysis of 56 patients with advanced gastric cancer treated with combination of intravenous and intra-arterial intensified neoadjuvant chemotherapy.

Li GL, Liu K, Bao Y, Cao JM, Xu J, Wang XL, Wu B, Li JS. Li GL, et al. Chin Med J (Engl). 2012 Mar;125(5):780-5. Chin Med J (Engl). 2012. PMID: 22490574 Clinical Trial.

8

Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.

He Q, Li G, Ji X, Ma L, Wang X, Li Y, Fan C. He Q, et al. Among authors: li y, li g. Tumour Biol. 2017 May;39(5):1010428317697571. doi: 10.1177/1010428317697571. Tumour Biol. 2017. PMID: 28475005 Free article.

9

Clinical efficacy of neoadjuvant chemotherapy regimens FLEEOX vs. XELOX in patients with initially unresectable advanced gastric cancer: a propensity score analysis.

Li Y, Chen J, He Q, Ji X, Wang X, Fan C, Li G. Li Y, et al. Among authors: li g. Oncotarget. 2017 Jun 28;8(49):86886-86896. doi: 10.18632/oncotarget.19004. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156843 Free PMC article.

10

Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.

Li Y, Wei Y, He Q, Wang X, Fan C, Li G. Li Y, et al. Among authors: li g. Sci Rep. 2018 Apr 18;8(1):6223. doi: 10.1038/s41598-018-24259-5. Sci Rep. 2018. PMID: 29670115 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49,081 results

Search Page

Filters